Upstart Shorts Rebuild After Earnings as Street Cuts Targets

Upstart Holdings has just printed Q3 results, and the market's immediate verdict is a wave of target-price cuts from Wall Street and a short book that refused to cover into the news.

The positioning story heading into November 3 earnings was one of cautious trimming by bears. That has reversed. Short interest ticked back up 2.1% over the week to 28.0% of the free float, roughly 27.3 million shares, essentially undoing the reduction that had built through late October from a peak above 29 million shares. The ORTEX short score of 74.9 places Upstart in the 3rd percentile of its universe, an extreme reading that has held near this level for the past two weeks without materially escalating. Borrow conditions remain loose relative to what the short position might suggest: the cost to borrow is just 0.68%, down 22% over the past month. Availability in the lending pool is 47%, a little looser than the 45% seen before the print, meaning there is still modest capacity for new shorts to be built without stress in the lending market. Options positioning has drifted slightly more defensive on the day, with the put/call ratio at 0.57, fractionally above its 20-day mean of 0.55, though the z-score of 0.79 is well within normal. Options traders are not panicking, but the mild shift toward puts is consistent with fresh uncertainty after a print.

The Street response to earnings has been uniformly downward on price targets, though without any rating changes. Morgan Stanley cut from $35 to $24 while holding Equal-Weight, Goldman Sachs trimmed from $28 to $24 at Neutral, and Truist Securities, still at Buy, dropped its target from $40 to $30. B. Riley and BTIG kept their Buy ratings but also pulled targets lower, to $42 and $40 respectively. Every firm that filed a note moved its target down. The consensus mean sits at $37.56, still a substantial premium to the $21.37 close, but that gap reflects how much expectation has already been walked back. Bulls, as laid out by the Benzinga case, point to June origination volume rising 48% year over year to $1.5 billion and a path toward committed capital structures and a potential bank charter that could durably lower funding risk. Bears counter that private credit redemption pressure could stall origination growth, and that higher loan loss rates would hit both investor demand and the fair-value marks on Upstart's own balance sheet. EPS momentum factor scores remain high, ranked in the 93rd and 94th percentile over 30 and 90 days, suggesting analysts had been lifting near-term estimates before the print. EV/EBITDA has drifted only modestly over the past 30 days, while the price-to-book multiple has compressed by roughly 0.3 points on the week alone, tracking a stock down 9.9% in seven sessions.

One governance data point adds texture. The ORTEX Alt Data layer flags that Upstart's remaining buyback authorization hit its smallest Q2 level on record (since 2022) at $122.1 million, down 45% against the same quarter last year. No dataset in the coverage has been measured to lead the company's reported figures, so this is context rather than signal. What is worth noting separately is a retail attention spike: Wikipedia views generated a z-score of 2.1 against Upstart's own trailing 90-day history as of late October, a reading that likely reflects elevated interest ahead of the earnings event rather than anything forward-looking about the business.

The insider register is also worth flagging. The most recent open-market buy of substance was CEO Paul Gu's purchase of 50,000 shares at $25.55 on September 10, a $1.28 million discretionary transaction with no 10b5-1 plan attached. Against that, President Sanjay Datta was a net seller across multiple open-market transactions in August and September, disposing of shares at prices now materially above the current level. Net insider activity over the past 90 days was a sale of roughly 107,000 shares valued at $3.1 million, a modest net outflow rather than anything dramatic in scale, but the direction is worth noting given the stock's move lower.

With earnings now behind it and the next scheduled event not until February 9, the focus shifts to whether the Street's freshly cut targets attract incremental buyers at $21 or whether the persistent short book, still at 28% of the float and barely changed despite the news, reflects a more structural view that the funding environment and credit conditions have not yet turned decisively in Upstart's favour.